Скачать или смотреть Delpharm Chooses Canada

Delpharm, a leading pharmaceutical developer and contract manufacturer from France!

Investment Highlights:
• Over $200 million invested in modernizing the Boucherville facility in Québec.
• 500 highly skilled jobs secured, boosting the region’s economic growth.
• Expansion of the site, installation of a cutting-edge filling line and equipment upgrades.
Healthcare Impact:
• The Boucherville site is the largest injectable facility in Canada.
• Produces 20 of the top 100 critical medications for surgical services and intensive care units.

The 10-year agreement between Delpharm and Sandoz ensures a stable supply of essential medicines for Canadians, enhancing healthcare.

#InvestInCanada is proud to support this investment and congratulate Delpharm, and our partners on this exciting milestone! #BesttoInvest